In this report we have demonstrated a significant reduction in the frequency of CD4+CD25hiFoxp3+ Treg in CVID patients, as previously described [1, 9] and we were the first to show a reduced frequency of CD39-expressing CD4+CD25hiFoxp3+ Treg in these patients. Here, ENTPD1 is linked to common variable immunodeficiency.